41
1% Alendronate Gel in Treatment of Chronic Periodontitis Among Smokers
Condition(s):Chronic PeriodontitisLast Updated:June 20, 2014Completed
FOSAMAX: 221 Clinical Trials, Page 5 of 23
Hide Studies Not Open or Pending
42
Pharmacokinetics of a Single 14C-labeled Dose of Risedronate or Alendronate Followed by Once-a-week Unlabeled Oral Dose
Condition(s):Osteopenia; OsteoporosisLast Updated:April 17, 2013Completed
43
Fosamax Bone Loss Study: Alendronate to Prevent Bone Loss
Condition(s):Perimenopausal Bone LossLast Updated:May 8, 2008Completed
44
Comparison of the Effect of an Ongoing Treatment With Alendronate or a Drug Holiday on the Fracture Risk in Osteoporotic Patients With Bisphosphonate Long Term Therapy
Condition(s):OsteoporosisLast Updated:February 12, 2019Terminated
45
The Use of Steovess/Binosto After Denosumab Discontinuation to Prevent Increase in Bone Turnover
Condition(s):Erosive OsteoarthritisLast Updated:April 22, 2022Completed
46
A Study of the Bioequivalence of 70-mg Alendronate and 70-mg Alendronate in Combination With 5600 IU Vitamin D (MK0217A-253)
Condition(s):OsteoporosisLast Updated:February 3, 2022Completed
47
Parathyroid Hormone (PTH) With Alendronate for Osteoporosis
Condition(s):OsteoporosisLast Updated:August 19, 2015Completed
48
99Tc-MDP in Postmenopausal Women With Differentiated Thyroid Cancer and Osteoporosis
Condition(s):Differentiated Thyroid Cancer; OsteoporosisLast Updated:November 17, 2021Completed
49
Efficacy and Safety of Alendronate in Chinese Children or Adolescents With Osteogenesis Imperfecta
Condition(s):Osteogenesis ImperfectaLast Updated:December 10, 2014Completed
50
RA Denosumab on Bone Microstructure Study
Condition(s):Rheumatoid ArthritisLast Updated:September 11, 2014Completed